早期和晚期癌症发病率的全球趋势
1Department of Food Science and Biotechnology, Dongguk University, Goyang, South Korea.
Journal of public health (Oxford, England)
|August 4, 2025
概括
全球癌症发病率因发病年龄,性别和癌症类型而异. 早期发病的癌症正在上升,但仍然比晚期发病的癌症少,观察到不同的地理模式.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 全球健康 全球健康
背景情况:
- 有证据表明,早期和晚期发作的癌症可能有不同的原因.
- 了解这些差异对于公共卫生战略至关重要.
研究的目的:
- 调查早期和晚期癌症发病率的全球分布,按性别分层.
- 分析基于发病年龄的癌症发病率的趋势和变化.
主要方法:
- 利用GLOBOCAN数据库在全球范围内查看年龄标准化发病率 (ASIR).
- 定义早期发病的癌症是那些在50岁之前被诊断出来的癌症,而晚期发病的癌症是那些在50岁或以上被诊断出来的癌症.
- 采用数据可视化技术来研究全球趋势.
主要成果:
- 在男性中,早期和晚期癌症的发病率最高集中在欧洲,而女性的发病率在地理上更分散.
- 早期癌症的ASIRs随着时间的推移稳步增加,但仍然低于两性晚期癌症的ASIRs.
- 甲状腺癌和肺癌分别在早期和晚期发病的男性中最常见. 对于两种发病类型,乳腺癌在女性中占主导地位. 结肠直肠癌在不同性别和年龄组中很常见.
结论:
- 早期和晚期癌症发病率的全球趋势表现出显著的异质性.
- 观察到性别,地理位置,时间趋势和特定癌症类型的变化.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Prevalence and Incidence
815
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
815
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Cancers Originate from Somatic Mutations in a Single Cell
12.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.8K


